Recombinant SLAMF7 (Elotuzumab Biosimilar) antibody

Catalog No. ABIN7597653

This Humanized Chimeric antibody specifically detects SLAMF7 (Elotuzumab Biosimilar) in not_set. It exhibits reactivity toward Human.

Quick Overview for Recombinant SLAMF7 (Elotuzumab Biosimilar) antibody (ABIN7597653)

Target: SLAMF7 (Elotuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This SLAMF7 (Elotuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-SLAMF7 (Elotuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Elotuzumab Biosimilar Antibody

Specificity: SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for SLAMF7 (Elotuzumab Biosimilar)

Target: SLAMF7 (Elotuzumab Biosimilar)

Alternative Name: Elotuzumab Biosimilar

Target Type: Biosimilar

Background: SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1

UniProt: Q9NQ25

CAS-No: 915296-00-3